In autoimmunity, the mechanisms that guarantee that our defense system does not attack our own body—tolerance to oneself—does not work properly. Multiple sclerosis, which affects one in every 1,000 people in Spain, is ...
Jan 19, 2022
0
272
A study conducted in two rural Massachusetts jails found that people with opioid use disorder who were incarcerated and received a medication approved to treat opioid use disorder, known as buprenorphine, were less likely ...
Jan 18, 2022
0
12
Cell cultures and animal studies show that TriSb92, a new molecule developed by the researchers, protects against coronavirus infection for at least eight hours even in cases of high exposure risk. In contrast to vaccine ...
Jan 10, 2022
0
19
Scientists led by Dr. Andrés Hidalgo at the Centro Nacional de Investigadores Cardiovasculares (CNIC) have discovered that the immune system's circulating neutrophils acquire different behavior patterns during inflammatory ...
Jan 5, 2022
0
85
Glioblastoma is widely considered the most aggressive brain cancer. Even with treatment, patient survival rates are low, with most living an average of 15–18 months after diagnosis. Because of the highly diverse characteristics ...
Dec 21, 2021
0
81
In the past decade, immunotherapy has helped save the lives of many cancer patients, many with lung cancer, who might have otherwise faced almost certain death sentences. However, only about 20% of patients who received immune ...
Dec 9, 2021
0
138
For most of us, vision is a major part of how we perceive the world, as it provides a constant stream of information about the objects that surround us. Yet there's a lot scientists still don't know about how our brains gather ...
Dec 8, 2021
0
4
Though many people with autism spectrum disorders also experience unusual gastrointestinal inflammation, scientists have not established how those conditions might be linked. Now Harvard Medical School and MIT researchers, ...
Dec 7, 2021
0
669
Ludwig Maximilians University Munich (LMU) immunologists have discovered how mutations in Roquin-1 trigger autoimmunity, but can also improve the body's fight against cancer cells.
Nov 26, 2021
0
61
An experimental compound reduced complications of type 1 and type 2 diabetes in mice—not by lowering blood sugar—but by countering its consequences: cell death, inflammation, and organ damage.
Nov 24, 2021
0
67
